← Every company
Who Lobbies for Inovio Pharmaceuticals Inc
Every firm filing a lobbying report has to name the individuals who worked the account and disclose the covered government positions they held. These are the people named on Inovio Pharmaceuticals Inc's filings who came out of such a job.
What INO spends on lobbying →Former staff lobbying
3
Members they worked for
3
named unambiguously
Position named as filed
1
agency or committee, not a member
Latest filing
2026
Former staff now lobbying
Sorted by how many members someone worked for. The chips in the last column are the other companies each person is also registered for.
| Lobbyist | Previously worked for |
|---|---|
| Eric BergrenChief of Staff, Rep. Brett Guthrie; Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director, Chief of Staff - Rep. Ron Lewis; Intern, Rep. Bill Bakerfiled 2026INO | Brett Guthrie· Chief of StaffRon Lewis· Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director, Chief of Staff |
| Paul EdattelChief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadeggfiled 2026INO | John Shadegg· Legislative Assistant & Legislative Director |
| Nicholas UehleckeSenior Advisor, Dept. of Health and Human Services; Professional Staff/Sr. Legislative Assistant, House Ways and Means Subcommitteefiled 2026INO | No member named |
Source: quarterly LD-2 lobbying reports filed under the Lobbying Disclosure Act. A member is linked only where the filing names them unambiguously; positions naming an agency, a committee or a surname shared by several members are shown as filed but not linked. Moving from government to lobbying is lawful and disclosed, which is why it is possible to count it here at all.
More on INO
Company overviewEverything on INO in one place, with the price.SEC filingsWhat INO's 8-Ks say happened: results, departures, auditor changes.Who owns itEvery manager reporting a position in INO.Funds holding itWhich funds and ETFs hold INO, and how big a bet.LobbyingWhat INO spends lobbying Congress, and on what.PatentsWhat INO is filing at the patent office.